INO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Inovio Pharmaceuticals Inc (INO) is not a strong buy at this time for a beginner investor with a long-term strategy. The technical indicators are bearish, financial performance is weak, and there are no significant positive catalysts or trading signals to suggest immediate upside potential. A hold position is recommended until clearer signs of recovery or growth emerge.
The technical indicators suggest a bearish trend. The MACD is below 0 and negatively contracting, RSI is neutral at 41.954, and moving averages indicate a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 1.165, with key support at 1.039 and resistance at 1.291.
NULL identified. There is no recent news or significant trading trends from hedge funds, insiders, or congress members. Gross margin remains at 100%, but this is not a strong growth indicator given the overall financial performance.
Technical indicators are bearish, and there is no recent AI Stock Pick or SwingMax signal. Additionally, there is no recent news or event-driven catalysts to drive the stock upward.
In Q4 2025, the company showed a severe decline in financial performance: Revenue dropped to 0 (-100% YoY), Net Income dropped to 3,764,880 (-119.42% YoY), and EPS dropped to 0.06 (-109.23% YoY). Gross Margin remained at 100%, but this is not indicative of growth given the revenue drop.
No recent analyst ratings or price target changes are available for INO.
